We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+16.76%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.6B
AUM Growth
+$2.65B
Cap. Flow
-$1.17B
Cap. Flow %
-4.57%
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$72.1M
2
PEP icon
PepsiCo
PEP
+$70.8M
3
AXP icon
American Express
AXP
+$70.7M
4
ADP icon
Automatic Data Processing
ADP
+$49.7M
5
SYF icon
Synchrony
SYF
+$47.9M

Sector Composition

Rank Sector Weight
1 Technology 23.67%
2 Healthcare 15.33%
3 Consumer Discretionary 10%
4 Financials 9.76%
5 Industrials 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMK icon
851
Weis Markets
WMK
$1.81B
$1.77M 0.01%
+43,400
New +$2.04M
ROL icon
852
Rollins
ROL
$16.1B
$1.76M 0.01%
63,513
-666
-1% -$17.3K
CORR
853
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$1.71M 0.01%
46,426
+27,626
+147% +$994K
AEO icon
854
American Eagle Outfitters
AEO
$2.48B
$1.7M 0.01%
+76,800
New +$1.58M
DBP icon
855
Invesco DB Precious Metals Fund
DBP
$256M
$1.7M 0.01%
46,900
+24,900
+113% +$916K
DBC icon
856
Invesco DB Commodity Index Tracking Fund
DBC
$1.96B
$1.68M 0.01%
105,870
+2,420
+2% +$37.9K
VIV icon
857
Telefônica Brasil
VIV
$18.9B
$1.68M 0.01%
139,006
+61,700
+80% +$779K
GTE icon
858
Gran Tierra Energy
GTE
$376M
$1.67M 0.01%
73,602
-66,533
-47% -$1.56M
ACHN
859
DELISTED
Achillion Pharmaceuticals
ACHN
$1.67M 0.01%
562,773
-599,854
-52% -$1.47M
EIRL icon
860
iShares MSCI Ireland ETF
EIRL
$79.1M
$1.67M 0.01%
40,000
LHX icon
861
L3Harris
LHX
$46.7B
$1.63M 0.01%
10,218
-4,075
-29% -$628K
EWX icon
862
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$661M
$1.62M 0.01%
36,395
ITCI
863
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.6M 0.01%
+131,611
New +$1.68M
WK icon
864
Workiva
WK
$3.96B
$1.6M 0.01%
31,600
+2,800
+10% +$123K
IVC
865
DELISTED
Invacare Corporation
IVC
$1.6M 0.01%
+191,200
New +$1.38M
KELYA icon
866
Kelly Services Class A
KELYA
$566M
$1.6M 0.01%
72,399
-91,887
-56% -$2.11M
XSLV icon
867
Invesco S&P SmallCap Low Volatility ETF
XSLV
$246M
$1.59M 0.01%
33,940
+2,960
+10% +$137K
LCTX icon
868
Lineage Cell Therapeutics
LCTX
$271M
$1.59M 0.01%
1,212,600
SMLV icon
869
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$250M
$1.58M 0.01%
17,320
+1,310
+8% +$118K
MEET
870
DELISTED
The Meet Group, Inc. Common Stock
MEET
$1.58M 0.01%
313,500
+242,200
+340% +$1.35M
CZR icon
871
Caesars Entertainment
CZR
$6.05B
$1.57M 0.01%
33,700
-70,840
-68% -$3.23M
FNKO icon
872
Funko
FNKO
$295M
$1.57M 0.01%
+72,200
New +$1.33M
EIS icon
873
iShares MSCI Israel ETF
EIS
$900M
$1.56M 0.01%
28,900
COKE icon
874
Coca-Cola Consolidated
COKE
$13.2B
$1.55M 0.01%
+54,000
New +$1.23M
EWS icon
875
iShares MSCI Singapore ETF
EWS
$1.28B
$1.53M 0.01%
64,563

Similar funds

Axa's Q1 2019 Portfolio in Review

As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in BlackBerry worth $40.1M.

  • Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
  • Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
  • Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
  • Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
  • Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
  • Axa opened 151 new positions and closed 137 in Q1 2019.
  • Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.

Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.